557 related articles for article (PubMed ID: 25904543)
21. Fluorescent mixed ligand copper(II) complexes of anthracene-appended Schiff bases: studies on DNA binding, nuclease activity and cytotoxicity.
Jaividhya P; Ganeshpandian M; Dhivya R; Akbarsha MA; Palaniandavar M
Dalton Trans; 2015 Jul; 44(26):11997-2010. PubMed ID: 26076117
[TBL] [Abstract][Full Text] [Related]
22. Copper Ion Attenuated the Antiproliferative Activity of Di-2-pyridylhydrazone Dithiocarbamate Derivative; However, There Was a Lack of Correlation between ROS Generation and Antiproliferative Activity.
Wang T; Fu Y; Huang T; Liu Y; Wu M; Yuan Y; Li S; Li C
Molecules; 2016 Aug; 21(8):. PubMed ID: 27556432
[TBL] [Abstract][Full Text] [Related]
23. The induction of apoptosis in SGC-7901 cells through the ROS-mediated mitochondrial dysfunction pathway by a Ir(III) complex.
Zhang C; Lai SH; Zeng CC; Tang B; Wan D; Xing DG; Liu YJ
J Biol Inorg Chem; 2016 Dec; 21(8):1047-1060. PubMed ID: 27796592
[TBL] [Abstract][Full Text] [Related]
24. Synthesis, characterization and anticancer activity studies of ruthenium(II) polypyridyl complexes on A549 cells.
Zeng CC; Jiang GB; Lai SH; Zhang C; Yin H; Tang B; Wan D; Liu YJ
J Photochem Photobiol B; 2016 Aug; 161():295-303. PubMed ID: 27288660
[TBL] [Abstract][Full Text] [Related]
25. Cu(ii)-TACN complexes selectively induce antitumor activity in HepG-2 cells via DNA damage and mitochondrial-ROS-mediated apoptosis.
Liu M; Song XQ; Wu YD; Qian J; Xu JY
Dalton Trans; 2020 Jan; 49(1):114-123. PubMed ID: 31793575
[TBL] [Abstract][Full Text] [Related]
26. The first copper(I) complex of anthrahydrazone with potential ROS scavenging activity showed significant in vitro anticancer activity by inducing apoptosis and autophagy.
Liu RX; Luo RY; Tang MT; Liu YC; Chen ZF; Liang H
J Inorg Biochem; 2021 May; 218():111390. PubMed ID: 33721719
[TBL] [Abstract][Full Text] [Related]
27. Anticancer activity of a new copper(II) complex with a hydrazone ligand. Structural and spectroscopic characterization, computational simulations and cell mechanistic studies on 2D and 3D breast cancer cell models.
Balsa LM; Ferraresi-Curotto V; Lavecchia MJ; Echeverría GA; Piro OE; García-Tojal J; Pis-Diez R; González-Baró AC; León IE
Dalton Trans; 2021 Jul; 50(28):9812-9826. PubMed ID: 34190268
[TBL] [Abstract][Full Text] [Related]
28. Induction of apoptosis in leukemia cell lines by new copper(II) complexes containing naphthyl groups via interaction with death receptors.
Fernandes C; Horn A; Lopes BF; Bull ES; Azeredo NFB; Kanashiro MM; Borges FV; Bortoluzzi AJ; Szpoganicz B; Pires AB; Franco RWA; Almeida JCA; Maciel LLF; Resende JALC; Schenk G
J Inorg Biochem; 2015 Dec; 153():68-87. PubMed ID: 26485179
[TBL] [Abstract][Full Text] [Related]
29. Copper complexes based on chiral Schiff-base ligands: DNA/BSA binding ability, DNA cleavage activity, cytotoxicity and mechanism of apoptosis.
Zhou XQ; Li Y; Zhang DY; Nie Y; Li ZJ; Gu W; Liu X; Tian JL; Yan SP
Eur J Med Chem; 2016 May; 114():244-56. PubMed ID: 26994692
[TBL] [Abstract][Full Text] [Related]
30. Mixed-ligand Cu(II) hydrazone complexes designed to enhance anticancer activity.
Mo Q; Deng J; Liu Y; Huang G; Li Z; Yu P; Gou Y; Yang F
Eur J Med Chem; 2018 Aug; 156():368-380. PubMed ID: 30015073
[TBL] [Abstract][Full Text] [Related]
31. In vitro and in vivo anti-proliferative evaluation of bis(4'-(4-tolyl)-2,2':6',2″-terpyridine)copper(II) complex against Ehrlich ascites carcinoma tumors.
Mahendiran D; Kumar RS; Viswanathan V; Velmurugan D; Rahiman AK
J Biol Inorg Chem; 2017 Oct; 22(7):1109-1122. PubMed ID: 28884428
[TBL] [Abstract][Full Text] [Related]
32. Selective anticancer copper(II)-mixed ligand complexes: targeting of ROS and proteasomes.
Ng CH; Kong SM; Tiong YL; Maah MJ; Sukram N; Ahmad M; Khoo AS
Metallomics; 2014 Apr; 6(4):892-906. PubMed ID: 24549332
[TBL] [Abstract][Full Text] [Related]
33. Development of Cu(II) 4-hydroxybenzoylhydrazone complexes that induce mitochondrial DNA damage and mitochondria-mediated apoptosis in liver cancer.
Jiang M; Yan Q; Fu Y; Meng L; Gai S; Pan X; Qin Y; Jiang C
J Inorg Biochem; 2024 Jul; 256():112550. PubMed ID: 38599004
[TBL] [Abstract][Full Text] [Related]
34. Piperidylthiosemicarbazones Cu(II) complexes with a high anticancer activity by catalyzing hydrogen peroxide to degrade DNA and promote apoptosis.
Qi J; Yao Q; Tian L; Wang Y
Eur J Med Chem; 2018 Oct; 158():853-862. PubMed ID: 30248656
[TBL] [Abstract][Full Text] [Related]
35. Synthesis, structure and in vitro pharmacological evaluation of a novel 2-oxo-1,2-dihydroquinoline-3-carbaldehyde (2'-methylbenzoyl) hydrazone bridged copper(II) coordination polymer.
Senthil Raja D; Ramachandran E; Bhuvanesh NS; Natarajan K
Eur J Med Chem; 2013 Jun; 64():148-59. PubMed ID: 23644198
[TBL] [Abstract][Full Text] [Related]
36. Structure-activity relationship study of copper(II) complexes with 2-oxo-1,2-dihydroquinoline-3-carbaldehyde (4'-methylbenzoyl) hydrazone: synthesis, structures, DNA and protein interaction studies, antioxidative and cytotoxic activity.
Raja DS; Bhuvanesh NS; Natarajan K
J Biol Inorg Chem; 2012 Feb; 17(2):223-37. PubMed ID: 21932155
[TBL] [Abstract][Full Text] [Related]
37. DNA binding, cleavage and cytotoxicity studies of three mononuclear Cu(II) chloro-complexes containing N-S donor Schiff base ligands.
Parsekar SU; Fernandes J; Banerjee A; Chouhan OP; Biswas S; Singh M; Mishra DP; Kumar M
J Biol Inorg Chem; 2018 Dec; 23(8):1331-1349. PubMed ID: 30302601
[TBL] [Abstract][Full Text] [Related]
38. A mononuclear Cu(II) complex with 5,6-diphenyl-3-(2-pyridyl)-1,2,4-triazine: Synthesis, crystal structure, DNA- and BSA-binding, molecular modeling, and anticancer activity against MCF-7, A-549, and HT-29 cell lines.
Anjomshoa M; Hadadzadeh H; Torkzadeh-Mahani M; Fatemi SJ; Adeli-Sardou M; Rudbari HA; Nardo VM
Eur J Med Chem; 2015; 96():66-82. PubMed ID: 25874332
[TBL] [Abstract][Full Text] [Related]
39. Synthesis, crystal structure, DNA interaction and anticancer activity of tridentate copper(II) complexes.
Li GY; Du KJ; Wang JQ; Liang JW; Kou JF; Hou XJ; Ji LN; Chao H
J Inorg Biochem; 2013 Feb; 119():43-53. PubMed ID: 23186647
[TBL] [Abstract][Full Text] [Related]
40. Synthesis, characterization, biological activity, DNA and BSA binding study: novel copper(ii) complexes with 2-hydroxy-4-aryl-4-oxo-2-butenoate.
Joksimović N; Baskić D; Popović S; Zarić M; Kosanić M; Ranković B; Stanojković T; Novaković SB; Davidović G; Bugarčić Z; Janković N
Dalton Trans; 2016 Sep; 45(38):15067-15077. PubMed ID: 27711668
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
